Keyphrases
Peripheral Neuropathy
100%
Patients with Diabetes
97%
Multiple Imputation
92%
Wolfram Syndrome
81%
Additive Hazards Model
81%
Type 2 Diabetes Mellitus (T2DM)
80%
Type 1 Diabetes Mellitus (T1DM)
80%
Alzheimer's Disease
79%
Computed Tomography
73%
Regression Analysis
71%
Imputation Approach
71%
Confidence Interval
66%
Simulation Study
65%
Programmed Death-ligand 1 (PD-L1)
64%
Overall Survival
64%
Older Adults
62%
Ischemic Conditioning
61%
Hospital Readmission
61%
Driving Behavior
61%
Magnetic Resonance Imaging
60%
Breast Cancer
60%
Cognitively Normal Older Adults
58%
Cerebrospinal Fluid
58%
Readmission
56%
Randomized Controlled Trial
56%
Time of Interest
54%
Diabetic Neuropathy
51%
Interval-censored Failure Time Data
51%
Patients with Heart Failure
49%
Metatarsophalangeal Joint
49%
Placental Pathology
47%
Failure Time Data
47%
High Risk
47%
Patient-Reported Outcomes Measurement Information System (PROMIS)
46%
Joint Deformities
45%
Heel Rise
45%
Checkpoint Immunotherapy
43%
Progression Rate
43%
Physical Health
43%
Quality of Life
43%
Alzheimer's Disease Biomarkers
43%
Surgeons
43%
Clinical Trials
42%
Inflammatory Bowel Disease
40%
Tumor mutation Burden
40%
Longitudinal Change
40%
Classical Hodgkin Lymphoma
40%
Head-and-neck Cancer
40%
Vitamin D Deficiency
40%
Midfoot
40%
Medicine and Dentistry
Biological Marker
91%
Diabetes Mellitus
83%
Neuropathy
83%
Neoplasm
72%
Cohort Analysis
69%
Breast Cancer
68%
Diabetic Neuropathy
66%
Overall Survival
65%
Recurrent Disease
64%
Diabetes
61%
Wolfram Syndrome
61%
Hazard Ratio
53%
Metatarsophalangeal Joint
52%
Maturity Onset Diabetes of the Young
51%
Magnetic Resonance Imaging
49%
Diseases
48%
Alzheimer's Disease
47%
Placental Pathology
46%
Patient-Reported Outcome
46%
Computer Assisted Tomography
46%
Congestive Heart Failure
44%
Outcome Assessment
43%
Severe Acute Respiratory Syndrome Coronavirus 2
43%
Cerebrospinal Fluid
40%
Alzheimer's Disease Biomarkers
40%
Ovarian Cancer
40%
Surgeon
40%
Systematic Review
40%
Radiofrequency Ablation
40%
Knee Pain
40%
Anterior Cruciate Ligament Reconstruction
40%
Cancer
39%
Placebo
39%
Placenta
38%
Prevalence
37%
Retrospective Cohort Study
37%
Malignant Neoplasm
36%
Bone Density
36%
Arthropathy
35%
Behavioral Change
34%
Randomized Controlled Trial
32%
Deterioration
31%
Immunohistochemistry
31%
COVID-19
31%
Histopathology
31%
Clinical Dementia Rating
30%
Immunotherapy
29%
Clinician
29%
Clinical Trial
28%
Osteoarthritis
28%